| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |